| MeSH term | MeSH ID | Detail |
|---|---|---|
| Pancreatic Neoplasms | D010190 | 77 associated lipids |
| Arteriosclerosis | D001161 | 86 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
Total
3
Norethindrone
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
Cross Reference
Introduction
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Norethindrone?
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Norethindrone
PubChem Associated disorders and diseases
What pathways are associated with Norethindrone
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Norethindrone?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Norethindrone?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Norethindrone?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Norethindrone?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Norethindrone?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Norethindrone
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Koch P | Allergic contact dermatitis from estradiol and norethisterone acetate in a transdermal hormonal patch. | 2001 | Contact Derm. | pmid:11205390 |
| Bhathena RK | The long-acting progestogen-only contraceptive injections: an update. | 2001 | BJOG | pmid:11213001 |
| Wu Z et al. | Simultaneous quantitative determination of norgestrel and progesterone in human serum by high-performance liquid chromatography-tandem mass spectrometry with atmospheric pressure chemical ionization. | 2000 | Analyst | pmid:11219053 |
| Saltevo J et al. | Plasma endothelin in postmenopausal women with type 2 diabetes mellitus and metabolic syndrome: a comparison of oral combined and transdermal oestrogen-only replacement therapy. | 2000 | Diabetes Obes Metab | pmid:11225744 |
| Rockson SG et al. | Plasma dopamine-beta-hydroxylase activity in oral contraceptive hypertension. | 1975 | Circulation | pmid:1122595 |
| Rozenberg S et al. | Constant estrogen, intermittent progestogen vs. continuous combined hormone replacement therapy: tolerability and effect on vasomotor symptoms. | 2001 | Int J Gynaecol Obstet | pmid:11226444 |
| Slick GL et al. | Hypertension, renal vein thrombosis and renal failure (occurring in a patient on an oral contraceptive agent). | 1975 | Clin. Nephrol. | pmid:1122661 |
| Weiner E and Johansson ED | Plasma levels of norethindrone after i.m. injection of 200 mg norethindrone enanthate. | 1975 | Contraception | pmid:1122756 |
| Kamischke A et al. | Intramuscular testosterone undecanoate and norethisterone enanthate in a clinical trial for male contraception. | 2001 | J. Clin. Endocrinol. Metab. | pmid:11232016 |
| Aisaka K | [Add back therapy for patients with endometriosis]. | 2001 | Nippon Rinsho | pmid:11235150 |
| pmid:11237600 | ||||
| Perera M et al. | The effects of transdermal estradiol in combination with oral norethisterone on lipoproteins, coagulation, and endothelial markers in postmenopausal women with type 2 diabetes: a randomized, placebo-controlled study. | 2001 | J. Clin. Endocrinol. Metab. | pmid:11238498 |
| Dören M et al. | Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy. | 2001 | Fertil. Steril. | pmid:11239541 |
| Garceau RJ et al. | Bleeding patterns of women using Lunelle monthly contraceptive injections (medroxyprogesterone acetate and estradiol cypionate injectable suspension) compared with those of women using Ortho-Novum 7/7/7 (norethindrone/ethinyl estradiol triphasic) or other oral contraceptives. | 2000 | Contraception | pmid:11239615 |
| Saha A et al. | Effects of oral contraceptive norethindrone on blood-lipid and lipid peroxidation parameters. | 2000 Nov-Dec | Acta Pol Pharm | pmid:11243250 |
| Elomaa K et al. | The possible role of enterohepatic cycling on bioavailability of norethisterone and gestodene in women using combined oral contraceptives. | 2001 | Contraception | pmid:11257243 |
| Boyd RA et al. | Minimal androgenic activity of a new oral contraceptive containing norethindrone acetate and graduated doses of ethinyl estradiol. | 2001 | Contraception | pmid:11292470 |
| pmid:11293581 | ||||
| Cacciatore B et al. | Randomized comparison between orally and transdermally administered hormone replacement therapy regimens of long-term effects on 24-hour ambulatory blood pressure in postmenopausal women. | 2001 | Am. J. Obstet. Gynecol. | pmid:11303197 |
| Pirroinen O and Rauramo L | Oral conception and uterine size-ultrasonic study. | 1975 | Am. J. Obstet. Gynecol. | pmid:1130457 |
| Nesit V and Valenta M | [Treatment of haemorrhage during insertion of IUD]. | 1975 | Cesk Gynekol | pmid:1131935 |
| Zhu J et al. | [The preparation of poly (DL-lactide) hollow fiber and the release of drug in vitro]. | 1997 | Sheng Wu Yi Xue Gong Cheng Xue Za Zhi | pmid:11326842 |
| Grinspoon S et al. | Changes in regional fat redistribution and the effects of estrogen during spontaneous weight gain in women with anorexia nervosa. | 2001 | Am. J. Clin. Nutr. | pmid:11333838 |
| Godsland IF | Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000. | 2001 | Fertil. Steril. | pmid:11334901 |
| Odmark IS et al. | Bleeding patterns in postmenopausal women using continuous combination hormone replacement therapy with conjugated estrogen and medroxyprogesterone acetate or with 17beta-estradiol and norethindrone acetate. | 2001 | Am. J. Obstet. Gynecol. | pmid:11349178 |
| Recruitment underway for oral contraceptive trial. | 1998 | AIDS Patient Care STDS | pmid:11361978 | |
| Bulent Tiras M et al. | Effects of a monthly injectable steroidal contraceptive, Mesigyna, on menstrual pattern, lipoproteins, and coagulation parameters. | 2001 | Contraception | pmid:11368988 |
| Høibraaten E et al. | The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism--results from a randomized, double-blind, clinical trial. | 2001 | Thromb. Haemost. | pmid:11372667 |
| Pacin J et al. | [Hormonal treatment of myomata (author's transl)]. | 1975 | Cesk Gynekol | pmid:1137876 |
| Dunn FG et al. | Malignant hypertension associated with use of oral contraceptives. | 1975 | Br Heart J | pmid:1138738 |
| Bhatnagar S et al. | Long-term contraception by steroid-releasing implants. II. A preliminary report on long-term contraception by a single silastic implant containing norethindrone acetate (ENTA) in women. | 1975 | Contraception | pmid:1139938 |
| Howard G et al. | Plasma levels of norethisterone in women receiving norethisterone oenanthate intramuscularly. | 1975 | Contraception | pmid:1139949 |
| Segre EJ et al. | Reduction of the oral contraceptive estrogen burden by alternate day estrogen administration. | 1975 | Contraception | pmid:1139955 |
| Smit J et al. | Counting the costs: comparing depot medroxyprogesterone acetate and norethisterone oenanthate utilisation patterns in South Africa. | 2001 | BMC Health Serv Res | pmid:11401729 |
| Inglis AM et al. | Lack of effect of rosiglitazone on the pharmacokinetics of oral contraceptives in healthy female volunteers. | 2001 | J Clin Pharmacol | pmid:11402638 |
| Varga L and Tamme E | Urinary hormone excretion patterns during low-dose progestogen administration. | 1975 | J. Int. Med. Res. | pmid:1140508 |
| Beck LR et al. | New long-acting injectable microcapsule contraceptive system. | 1979 | Am. J. Obstet. Gynecol. | pmid:114054 |
| Van Vliet H et al. | Biphasic versus monophasic oral contraceptives for contraception. | 2001 | Cochrane Database Syst Rev | pmid:11406026 |
| Blom MJ et al. | Metabolism of norethisterone and norethisterone derivatives in rat uterus, vagina, and aorta. | 2001 | Drug Metab. Dispos. | pmid:11408363 |
| Wihlbäck AC et al. | Sensitivity to a neurosteroid is increased during addition of progestagen to postmenopausal hormone replacement therapy. | 2001 | Neuroendocrinology | pmid:11408781 |
| Peverill RE et al. | Effects of combined oral hormone replacement therapy on tissue factor pathway inhibitor and factor VII. | 2001 | Clin. Sci. | pmid:11410120 |
| Ahmad ME et al. | Evaluation of genotoxic potential of synthetic progestins-norethindrone and norgestrel in human lymphocytes in vitro. | 2001 | Mutat. Res. | pmid:11423341 |
| Moghissi KS | Symposium on scanning electron microscopy of fertility and infertility, Eighth World Congress of Fertility and Sterility, Buenos Aires, Argentina, November 1974. Endometrium and endosalpinx of women treated with microdose progestogens. | 1975 | J Reprod Med | pmid:1142361 |
| pmid:11424084 | ||||
| Kappus H and Bolt HM | Proceedings: Covalent protein binding of norethisterone and norethisterone-4,5-epoxide in liver microsomes. | 1975 | Naunyn Schmiedebergs Arch. Pharmacol. | pmid:1143488 |
| Obruca A et al. | Ovarian function during and after treatment with the new progestagen Org 30659. | 2001 | Fertil. Steril. | pmid:11438328 |
| Ventura P et al. | Continuous combined hormone replacement therapy with oral 17beta-estradiol and norethisterone acetate improves homocysteine metabolism in postmenopausal women. | 2001 Jul-Aug | Menopause | pmid:11449082 |
| Williams JG et al. | Metabolism of 4-3-H- and 4-14-C-17alpha-ethynylestradiol 3-methyl ether (mestranol) by women. | 1975 | Steroids | pmid:1145671 |
| Yeung DL and Chan PL | Effects of a progestogen and a sequential type oral contraceptive on plasma vitamin A, vitamin E, cholesterol and triglycerides. | 1975 | Am. J. Clin. Nutr. | pmid:1146718 |
| Goldzieher JW et al. | Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins. | 1975 | Am. J. Obstet. Gynecol. | pmid:1146928 |